Breaking News

SAB Biotherapeutics Inc (SABS)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

4.010 +0.010 +0.25%

- Closed. Currency in USD ( Disclaimer )

Type: Equity

Market: United States

Volume: 4,830
Bid/Ask: 0.000 / 0.000
Day's Range: 4.010 - 4.205

SAB Biotherapeutics Inc Company Profile

Get an in-depth profile of SAB Biotherapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ORD

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases. The company also uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors or plasma. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 1 trials in delaying the onset or progression of type 1 diabetes. Further, the company develops SAB-176, a multivalent, broadly neutralizing - human polyclonal immunoglobulin therapeutic candidate, currently in Phase 2a development for the treatment or prevention of severe influenza. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.

Contact Information

Address 777 W 41st St. Suite 401
Miami Beach, 33140
United States

Phone 605 679 6980

Fax -

Web www.sabbiotherapeutics.com

Top Executives

Name	Age	Since	Title
Ilan Katz	48	-	Director
Jeffrey G. Spragens	79	2020	Independent Non-Executive Chairman of the Board
Samuel J. Reich	46	2020	CEO, CFO & Director
James J. Martin	54	2020	Independent Director
Stephen D. Collins	68	2020	Independent Director
William Polvino	-	2021	Director
David Link	-	2021	Director
Eddie Joe Sullivan	-	2021	Director
Christine Hamilton	-	2021	Director
Mervyn Turner	-	2021	Director
Helen K. Ellias	-	2023	Director
Jim Robl	-	-	Member of Scientific Advisory Board
Scott Giberson	54	2022	Independent Director
Stephen E. Gitelman	-	2020	Member of Scientific Advisory Board
Arturo Casadevall	-	-	Member of Scientific Advisory Board
Edward D. Hamilton	-	2021	Co-Founder & Board Observer
Jeffrey G. Spragens	82	2020	Independent Director
Mark J. Ratain	69	2022	Member of Scientific Advisory Board
Erick J. Lucera	56	2023	Independent Director
Juan Alvarez	-	2022	Member of Scientific Advisory Board
David Charles Link	68	2018	Independent Vice Chairman
Christine E. Hamilton	68	2014	Co-Founder & Independent Director
Michael Haller	-	-	Member of Scientific Advisory Board
Andrew D. Moin	40	2023	Independent Director
William J. Polvino	64	2019	Independent Director
Eddie Joe Sullivan	57	2014	Co-Founder, President & Director
Jay S. Skyler	77	2024	Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

SABS Comments

Write your thoughts about SAB Biotherapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Javi Sempere Oct 15, 2021 8:25AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

oooh Van

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="218785446">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="218785446" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="218785446" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="218785446">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	39,487.2	+99.4	+0.25%
US 500	5,218.1	+4.0	+0.08%
Dow Jones	39,512.84	+125.08	+0.32%
S&P 500	5,222.68	+8.60	+0.16%
Nasdaq	16,340.87	-5.40	-0.03%
S&P 500 VIX	12.55	0.00	0.00%
Dollar Index	105.175	+0.071	+0.07%

Crude Oil WTI	78.20	-1.06	-1.34%
Brent Oil	82.78	-1.10	-1.31%
Natural Gas	2.252	-0.049	-2.13%
Gold	2,366.80	+26.50	+1.13%
Silver	28.395	+0.030	+0.11%
Copper	4.6520	+0.0670	+1.46%
US Soybeans	1,218.75	+10.75	+0.89%

U.S. 10Y	4.500	-0.004	-0.08%
U.S. 30Y	4.642	+-0.004	+-0.08%
U.S. 5Y	4.516	+-0.002	+-0.04%
U.S. 3M	5.406	+0.015	+0.28%
US 10Y T-Note	108.72	-0.38	-0.34%
Euro Bund	130.88	-0.14	-0.11%
10-2 Yield Spread	-34.29	+2.85	+-7.67%

Apple	183.05	-1.27	-0.69%
Alphabet A	168.65	-1.31	-0.77%
Tesla	168.47	-3.50	-2.04%
Amazon.com	187.48	-2.02	-1.07%
Netflix	610.87	-1.22	-0.20%
Meta Platforms	476.20	+0.78	+0.16%
Bank of America	38.45	+0.17	+0.43%

Recent Quotes

	Name	Price	Chg.	Chg. %
	SABS	4.010	+0.010	+0.25%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	168.47	-2.04%	71.53M
AAPL	183.05	-0.69%	40.34M
AMD	151.92	-0.31%	37.43M
AMZN	187.48	-1.07%	34.07M
NVDA	898.78	+1.27%	33.22M
MSFT	414.74	+0.59%	12.66M
BRKa	621,170	+0.87%	14.00K

Name	Last	Chg. %	Vol.
MTD	1,513.03	+17.25%	425.09K
GEN	23.46	+15.34%	13.62M
ANET	314.10	+6.09%	5.16M
CHTR	275.55	+4.40%	1.77M
WAT	350.78	+4.27%	710.53K
FICO	1,330.02	+3.36%	424.53K
CBRE	90.23	+3.19%	1.61M

Name	Last	Chg. %	Vol.
AKAM	91.19	-11.00%	9.72M
PODD	165.90	-6.55%	3.16M
MRNA	117.31	-4.39%	4.23M
IP	38.58	-3.16%	6.28M
ALGN	271.70	-3.10%	729.75K
CZR	36.18	-3.00%	5.22M
ALB	129.60	-2.96%	1.87M